Clinical Trials Logo
  1. Home
  2. Cerebral Ischemia
  3. NCT03607565
  4. Details
NCT03607565 Clinical Trial

A New Parameter Derived From DSA to Evaluate Cerebral Perfusion

Cerebral Ischemia Clinical Trial

Official title:
The Association Between a New Parameter Derived From DSA and Outcomes in Cerebral Ischemia

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03607565
Other study ID # Hnn
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 15, 2018
Est. completion date July 15, 2038

Study information
Verified date August 2023
Source Xi'an No.3 Hospital
Contact Tian Ye, doctor
Phone +8613519131549
Email chhty@sina.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This observational study focus on a new parameter of cerebral perfusion derived form digital substraction angiography.

Description:

Ischemic cerebrovascular disease is an important cause of death and disability in the world. Digital Subtraction Angiography (DSA) is the golden index for evaluating cerebral blood vessels. We introduced a new parameter derived from DSA to evaluate the perfusion to predict the outcomes in acute stroke with large vessel occlusion. To study the possible relationship between the new parameter of cerebral perfusion derived from DSA and outcomes in cerebral ischemia（modified Rankin Scale）, we intend to retrospectively analyze the images derived from patients who undergone the DSA and follow-up outcomes（modified Rankin Scale）.

Recruitment information / eligibility
Status Recruiting
Enrollment 30000
Est. completion date July 15, 2038
Est. primary completion date July 15, 2028
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. Cerebral ischemia 2. patients undergone DSA Exclusion Criteria: 1.cerebral hemorrhage

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China Xi'an No.3 Hospital Xi'an Shaanxi

Sponsors (1)
Lead Sponsor Collaborator
Xi'an No.3 Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary the outcomes between good perfusions and poor perfusions Results are reported as odds ratios (ORs) with 95% confidence intervals (CIs). 3 months to 2 years
Secondary the outcomes between good perfusions and middle perfusions Results are reported as odds ratios (ORs) with 95% confidence intervals (CIs). 3 months to 2 years
See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT04167527 - Endovascular Therapy for Low NIHSS Ischemic Strokes Phase 2/Phase 3
Recruiting NCT04583163 - Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
Completed NCT01436812 - Effect of Positive End Expiratory Pressure (PEEP) on Cerebral Oxymetry During Laparoscopy N/A
Terminated NCT00141011 - Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Phase 3
Recruiting NCT05053932 - Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia
Completed NCT04437862 - A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke N/A
Completed NCT00598819 - A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers Phase 1
Completed NCT00207961 - The Threshold Value of Regional Cerebral Oxygenation in Detecting Cerebral Ischemia N/A
Not yet recruiting NCT04696523 - Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage Phase 2
Completed NCT02351518 - Cerebral Autoregulation and Vasospasm in Patients With TBI
Completed NCT01546636 - The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position N/A
Completed NCT04047563 - Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke Phase 3
Completed NCT05087836 - Correlation of Cerebral Oxygen Saturation Measured From 2 Sensor Sites: Forehead vs. Temporal
Completed NCT02448069 - Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke Phase 2
Completed NCT02147275 - Monitoring Hypertensive Patients's Cerebral Oxygen Saturation N/A
Completed NCT01875055 - Reversing Cerebral Oxygen Desaturations Greater That 10% of Baseline Values Using NIRS in the ICU N/A
Completed NCT02389647 - Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury
Completed NCT02643030 - Hypercapnia During Shoulder Arthroscopy N/A
Completed NCT01436799 - Desflurane Versus Propofol in the Sitting Position N/A